Dentsply International (NASDAQ:XRAY)‘s stock had its “neutral” rating reaffirmed by Zacks in a research note issued on Wednesday, StockRatingsNetwork.com reports. They currently have a $48.00 price objective on the stock. Zacks‘s price objective suggests a potential upside of 5.10% from the company’s current price.
Zacks’ analyst wrote, “DENTSPLY’s first-quarter 2014 earnings per share grew 13.5% to $0.59, beating the Zacks Consensus Estimate by $0.04. Net revenues fell 0.3% to $730.1 million and missed the Zacks Consensus Estimate of $752 million. Though U.S. recorded a modest sales growth, disappointing sales in Europe dampened revenue growth. However, we believe a diversified product range and significant investments in product innovation should help the company expand its share in the dental market. Management expects a 5.1-8.5% rise in earnings per share in 2014 based on better global market conditions. As such, we reaffirm our Neutral recommendation on DENTSPLY with a target of $48.00.”
Separately, analysts at Ned Davis Research downgraded shares of Dentsply International from a “buy” rating to a “neutral” rating in a research note on Monday, February 10th. Four equities research analysts have rated the stock with a hold rating and four have issued a buy rating to the company’s stock. The company has an average rating of “Buy” and a consensus target price of $49.60.
Shares of Dentsply International (NASDAQ:XRAY) opened at 45.67 on Wednesday. Dentsply International has a 52-week low of $39.90 and a 52-week high of $50.99. The stock has a 50-day moving average of $45.46 and a 200-day moving average of $46.5. The company has a market cap of $6.488 billion and a P/E ratio of 21.05.
Dentsply International (NASDAQ:XRAY) last released its earnings data on Tuesday, May 6th. The company reported $0.59 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.56 by $0.03. The company had revenue of $730.10 million for the quarter, compared to the consensus estimate of $747.27 million. During the same quarter in the previous year, the company posted $0.52 earnings per share. The company’s revenue for the quarter was down .3% on a year-over-year basis. Analysts expect that Dentsply International will post $2.52 EPS for the current fiscal year.
DENTSPLY International Inc (NASDAQ:XRAY) is a designer, developer, manufacturer and marketer of a range of dental products.
To view Zacks’ full report, visit Zacks’ official website.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.